Germany TED / Vergabe.de contract award · ocds-ted-283459-2026-3
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum W
DAK-Gesundheit awarded a contract of undisclosed value to ETHYPHARM GmbH for Healthcare & Medical in April 2026 — one of 389 awards this buyer has made.
24 Apr 2026
Award date
Not disclosed
Contract value
Buying agency
DAK-Gesundheit 389 Awards
€581K Avg award
Winning supplier
ETHYPHARM GmbH 1 Award
1 Buyer
Contract description
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dexketoprofen, ATC M01AE17 für die Zeit 01.03.2024 - 31.03.2026
Premium
Related awards · DAK-Gesundheit
389 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Tender no.SupplierAmountDateSector
- ocds-ted-210283-2024Aktivital GmbH€9.1M10 Apr 2024 Healthcare
- ocds-ted-211590-2024Kraaibeek GmbH€2.5M10 Apr 2024 Healthcare
- ocds-ted-828775-2025news aktuell GmbH€38.0K12 Dec 2025 IT
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for DAK-Gesundheit and ETHYPHARM GmbH — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back